β-1 and β-2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses

OE Brodde - Pharmacology & therapeutics, 2008 - Elsevier
β-1 and β-2 adrenoceptors (AR) play a pivotal role in regulation of the activity of the
sympathetic nervous system and agonists and antagonists at both β AR subtypes are …

Inhaled β2-Adrenoceptor Agonists: Cardiovascular Safety in Patients with Obstructive Lung Disease

M Cazzola, MG Matera, CF Donner - Drugs, 2005 - Springer
Although large surveys have documented the favourable safety profile of β 2-adrenoceptor
agonists (β 2-agonists) and, above all, that of the long-acting agents, the presence in the …

Subtype-specific β-adrenoceptor signaling pathways in the heart and their potential clinical implications

RP Xiao, W Zhu, M Zheng, K Chakir, R Bond… - Trends in …, 2004 - cell.com
Abstract β-Adrenoceptor stimulation serves as the most powerful means to increase cardiac
output in response to stress or exercise. However, sustained β-adrenoceptor stimulation …

Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block …

M Zaugg, L Bestmann, J Wacker, E Lucchinetti… - …, 2007 - pubs.asahq.org
Background: Neuraxial blockade is used as primary anesthetic technique in one third of
surgical procedures. The authors tested whether bisoprolol would protect patients at risk for …

Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage

JG Zaroff, L Pawlikowska, JC Miss, S Yarlagadda, C Ha… - Stroke, 2006 - Am Heart Assoc
Background and Purpose—Cardiac abnormalities occur commonly after subarachnoid
hemorrhage (SAH) and may be caused by excessive release of catecholamines from the …

β‐adrenergic receptor gene polymorphisms and β‐blocker treatment outcomes in hypertension

MA Pacanowski, Y Gong… - Clinical …, 2008 - Wiley Online Library
Numerous studies have demonstrated that β1‐and β2‐adrenergic receptor gene (ADRB1
and ADRB2) variants influence cardiovascular risk and β‐blocker responses in hypertension …

Pharmacogenetic factors affecting β-blocker metabolism and response

CD Thomas, JA Johnson - Expert opinion on drug metabolism & …, 2020 - Taylor & Francis
Introduction β-blockers are among the most widely prescribed of all drugs, used for
treatment of a large number of cardiovascular diseases. Herein we evaluate literature …

β1‐ and β2‐Adrenoceptor polymorphisms and cardiovascular diseases

OE Brodde - Fundamental & clinical pharmacology, 2008 - Wiley Online Library
Abstract β1‐and β2‐Adrenoceptors (AR) play a pivotal role in regulation of the
cardiovascular system. Both β‐AR subtypes are polymorphic. There are two major single …

Increased risk of acute myocardial infarction and elevated levels of C-reactive protein in carriersof the Thr-87 variant of the ATP receptor P2Y11

S Amisten, O Melander, AK Wihlborg… - European heart …, 2007 - academic.oup.com
Aims Extracellular ATP acting on the P2Y11 receptor regulates inflammatory cells. We
hypothesized that polymorphisms in the receptor could influence the risk of acute myocardial …

The Arg389Gly β1-adrenoceptor gene polymorphism determines contractile response to catecholamines

K La Rosée, M Huntgeburth… - Pharmacogenetics …, 2004 - journals.lww.com
Objectives Recently, the Arg389Gly β 1-adrenoceptor (β 1 AR) gene polymorphism has
been detected. The Arg variant exhibited increased responsiveness to agonist-induced …